Navigation Links
New injectable gels toughen up after entering the body
Date:11/15/2012

CAMBRIDGE, MA -- Gels that can be injected into the body, carrying drugs or cells that regenerate damaged tissue, hold promise for treating many types of disease, including cancer. However, these injectable gels don't always maintain their solid structure once inside the body.

MIT chemical engineers have now designed an injectable gel that responds to the body's high temperature by forming a reinforcing network that makes the gel much more durable, allowing it to function over a longer period of time.

The research team, led by Bradley Olsen, an assistant professor of chemical engineering, described the new gels in a recent issue of the journal Advanced Functional Materials. Lead author of the paper is Matthew Glassman, a graduate student in Olsen's lab. Jacqueline Chan, a former visiting student at MIT, is also an author.

Olsen and his students worked with a family of gels known as shear thinning hydrogels, which have a unique ability to switch between solid-like and liquid-like states. When exposed to mechanical stress such as being pushed through an injection needle these gels flow like fluid. But once inside the body, the gels return to their normal solid-like state.

However, a drawback of these materials is that after they are injected into the body, they are still vulnerable to mechanical stresses. If such stresses make them undergo the transition to a liquid-like state again, they can fall apart.

"Shear thinning is inherently not durable," Olsen says. "How do you undergo a transition from not durable, which is required to be injected, to very durable, which is required for a long, useful implant life?"

The MIT team answered that question by creating a reinforcing network within their gels that is activated only when the gel is heated to body temperature (37 degrees Celsius).

Shear thinning gels can be made with many different materials (including polymers such as polyethylene glycol, or PEG), but Olsen's lab is focusing on protein hydrogels, which are appealing because they can be designed relatively easily to promote biological functions such as cellular adhesion and cell migration.

The protein hydrogels in this study consist of loosely packed proteins held together by links between protein segments known as coiled coils, which form when two or three helical proteins coil into a ropelike structure.

The MIT researchers designed their hydrogel to include a second reinforcing network, which takes shape when polymers attached to the ends of each protein bind together. At lower temperatures, these polymers are soluble in water, so they float freely in the gel. However, when heated to body temperature, they become insoluble and separate out of the watery solution. This allows them to join together and form a sturdy grid within the gel, making it much more durable.

The researchers found that gels with this reinforcing network were much slower to degrade when exposed to mechanical stress and were significantly stiffer.

Another advantage of these gels is that they can be tuned to degrade over time, which would be useful for long-term drug release. The researchers are now working on ways to control this feature, as well as incorporating different types of biological functions into the gels.


'/>"/>

Contact: Sarah McDonnell
s_mcd@mit.edu
617-253-8923
Massachusetts Institute of Technology
Source:Eurekalert

Related biology news :

1. Toughened silicon sponges may make tenacious batteries
2. Neurons made from stem cells drive brain activity after transplantation in laboratory model
3. Bone marrow stem cells do not improve short-term recovery after heart attack
4. After long-ago mass extinction, global warming hindered species recovery
5. Clinical hypnosis can reduce hot flashes after menopause, Baylor study shows
6. Why astronauts experience low blood pressure after returning to Earth from space
7. Viruses not to blame for chronic fatigue syndrome after all
8. King Richard III search in new phase after discovery has potential to rewrite history
9. Is long-term weight loss possible after menopause?
10. Dawn of humanity illuminated in special journal edition 50 years after the Leakeys
11. Dawn of humanity illuminated in special journal edition - 50 years after the Leakeys
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2016)... BANGALORE, India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a ... ), and Onegini today announced a partnership to ... banking solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... banks to provide their customers enhanced security to ...
(Date:4/19/2016)... UAE, April 20, 2016 The ... as a compact web-based "all-in-one" system solution for all ... fingerprint reader or the door interface with integration authorization ... access control systems. The minimal dimensions of the access ... into the building installations offer considerable freedom of design ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016  The Prostate Cancer Foundation (PCF) is pleased to announce ... cures for prostate cancer. Members of the Class of 2016 were selected from ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , a ... $1 million in debt financing from Silicon Valley Bank ... automation and to advance its drug development efforts, as ... facility. "SVB has been an incredible strategic ... services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... ... 23, 2016 , ... STACS DNA Inc., the sample tracking software company, today ... Laboratory, has joined STACS DNA as a Field Application Specialist. , “I am ... and COO of STACS DNA. “In further expanding our capacity as a scientific integrator, ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
Breaking Biology Technology: